prod:prod_dcx-login
Xpert® Xpress Respiratory Tests
Help stop the spread of infectious diseases with Cepheid’s portfolio of easy-to-use on-demand tests.
NOW AVAILABLE: FDA Cleared Moderate Complexity and CLIA waved Xpert® Xpress CoV-2/Flu/RSV plus and Xpert Xpress CoV-2 plus for GeneXpert® Dx Infinity and GeneXpert Xpress Systems.
These products can now be used in both Moderate Complexity (MC) and CLIA Waived laboratory settings on GeneXpert® Xpress systems.
Important for users of FDA cleared Xpert Xpress CoV-2/Flu/RSV plus (XPRS4PLEX-10) a new version of the Assay Definition File (ADF) has been released, and all users are requested to update to the most updated version of the ADF.
Find product information including the ADF update and IFU: Cepheid website | edoc
For a copy of the most recent customer letter with important links and complete details visit https://cepheid.widen.net/s/kdcqnjvdzr/cepheid-cw-mc-dual-launch-respiratory-us-ivd-10198-english
Products
Xpert® Xpress CoV-2/Flu/RSV plus (FDA cleared)
On-demand 4-in-1 PCR test delivering actionable results with less than 1 minute of hands-on time. FDA cleared: moderate complexity and CLIA waived
Xpert® Xpress CoV-2 plus (FDA cleared)
Designed with 3 gene targets for a rapid, robust detection of SARS-CoV-2. FDA cleared: moderate complexity and CLIA-Waived
Xpert® Xpress Strep A
Delivers accurate and timely results that optimizes fast treatment decisions
Xpert® Xpress CoV-2 plus
Designed with 3 gene targets for a rapid, robust detection of SARS-CoV-2
Xpert® Xpress CoV-2/Flu/RSV plus
Actionable rapid respiratory results to meet the challenges of co-circulating respiratory viruses
Xpert® Xpress Flu
A multi-target approach for the detection of influenza to mitigate potential impact of genetic shift and drift on strain detection
View Our Global Products
Select from a category above